Non-Executive Member (since May 12, 2021)
Read more
Srishti Gupta
Non-Executive Member (since June 13, 2024)
Read more
Bart Filius
Chairman of the Board (since June 13, 2024)
Read more
Jean-Paul Clozel
Vice-Chairman and Lead Independent Director
Read more
Mathieu Simon
Date of birth: May 6, 1956
Nationality: French
Education: Certified in internal medicine at the Faculty of Medicine, Paris Diderot University (Paris 7).
Professional background: Former Chairman of the Board of Cellartis AB, 2012–2014; Executive Vice President, Chief Operating Officer of Cellectis Group, 2013–2018; CEO of Cellectis Therapeutics, 2012–2013, and CEO of Ectycell, 2012–2014; Managing Director, Head of Global Pharma operations at Pierre Fabre SA, 2010–2011. Various management and EU regional management roles as well as senior corporate functions at Wyeth Pharmaceuticals.
Other activities and functions: Member of the Board of Directors of one non-listed company, Aileens Pharma (Chairman). Senior Advisor at Messier & Associés.
Mathieu Simon
Vice-Chairman and Lead Independent Director (since June 13, 2020)
Chairman of the Board (since 13 June, 2024)
Date of birth: April 3, 1955
Nationality: Swiss and French
Education: Medical degree in France; further training in pharmacology and physiology at the University of Montreal, Canada, and the University of California, San Francisco, US.
Professional background: Practicing cardiologist, 1980–1985. Head of Drug Discovery Group in the Cardiovascular Department of F. Hoffmann-La Roche Ltd, 1985–1997. Founder of Actelion in 1997 and CEO 2000–2017.
Awards: Doctor honoris causa from the University of Basel.
Other activities and functions: None.
Jean-Paul Clozel
Non-Executive Member (since June 13, 2024)
Date of birth: July 05, 1970
Nationality: Dutch
Education: MBA degree from INSEAD, France and a bachelor’s degree in business from Nyenrode University, the Netherlands.
Professional background: Held various executive positions at Galapagos (Chief Financial Officer and Chief Operating Officer) from 2014-2023, culminating as President from 2021 to June 2023; various executive positions at Sanofi (2001-2014): strategy consultant at Arthur D. Little.
Other activities and functions: member of the Board and Chairman of the Audit Committee of ProQR Therapeutics since 2019.
Bart Filius
Non-Executive Member (since May 12, 2021)
Date of birth: May 6, 1976
Nationality: American
Education: Doctor of Medicine (MD) from Harvard Medical School; Master in Public Policy (MPP) focusing on international development at Harvard Kennedy School of Government; Master’s degrees from the Department of Pathology at the University of Cambridge and the Department of Molecular and Cellular Biology at the Harvard Graduate School of Arts and Sciences; Bachelor’s degree from Harvard College.
Professional background: Held various positions at McKinsey & Company: Global Director, Alumni Strategy and Engagement, 2020–2021; Director of Global Development Programs, 2016–2020; Regional Manager, Diversity & Inclusion, 2014–2016; Senior Expert for the McKinsey Global Health Practice, 2003– .
Other activities and functions: Board Member at Invivyd (a listed company), BackPack Foundation, Norrsken Foundation, American Swiss Foundation and Partners in Health, a nonprofit corporation.
Srishti Gupta
Non-Executive Member (since May 4, 2023)
Date of birth: 1963
Nationality: French
Education: Doctorate in Pharmacy from the Faculty of Pharmacy, Paris Descartes University (Paris V) and MBA in Marketing and Finance from the University of Chicago Booth School of Business.
Professional background: Management positions at Abbott Diagnostics and Abbott Pharmaceutical Products, 1985–1991, Sanofi Winthrop, 1991–1996, and Merck & Co., 1996–2007; General Manager, Roche France, 2007–2012; Global Head of Roche Partnering, 2012–2018.
Other activities and functions: CEO of Boston Pharmaceuticals, Senior Partner at Gurnet Point Capital, and member of the Board of Directors of Teal Bio, Inc. (a non-listed company).
Sophie Kornowski
Non-Executive Member (since May 13, 2020)
Date of birth: January 24, 1965
Nationality: American
Education: Master of Laws degrees from Cornell University & New York University and member of the New York State Bar.
Professional background: President, COO, and CFO of National Resilience, Inc., 2020–2024; Chief Financial Officer and Chief Business Officer at Sarepta Therapeutics, 2012–2020; Senior Vice President at Celgene, 2006–2012; Held senior roles in business development & tax at Pfizer and began his career at Ernst & Young.
Other activities and functions: Board member of Crispr Therapeutics; Member of the Board of Directors of the non-listed company Epirium Bio.
Sandy Mahatme
Sophie Kornowski
Read more
Non-Executive Member (since May 4, 2023)
Sandy Mahatme
Read more
Non-Executive Member (since May 13, 2020)
